Role of immunohistochemical markers in evaluating malignant transformation of oral submucous fibrosis
A systematic review
Keywords:
COX2, e-cadherin, oral submucous fibrosis, ?-SMA, ?-cateninAbstract
Objective(s): We present a systematically to identify, evaluate and assess the role of Immunohistochemical markers in Malignant Transformation of Oral Submucous Fibrosis (OSF). Materials and Methods: Extensive literature search was done to identify eligible through “MEDLINE”/ “PubMed”, “Scopus” and “Cochrane library” were searched for relative studies until December 2021. The included studies were published in English language were mainly retrospective original research\.These studies mainly evaluated the role of Immunohistochemical markers in Malignant Transformation of Oral Submucous Fibrosis. Results: Thirteen studies were included in the present study which had total of 549 cases. Most of the studies suggested use of combined biomarker model or panel of antibodies to minimize the risk of bias. Almost all the studies used ANOVA and chi-square test while kappa test analysis for interobserver variability test. Conclusions: The significance of immunohistochemical markers has been shown in study which can significantly contribute in diagnosing early event in process of malignant transformation of suspicious OSF cases so that better treatment plan could be formulated for better prognosis. More efforts should be emphasized on combination of \antibodies and its importance in target drug therapy.
Downloads
References
Bavle, R. M., Paremala, K., Sowmya, M., Sudhakara, M., Reshma, V., & Hosthor, S. (2020). Predicting the malignant transformation of oral submucous fibrosis using quantitative biomarkers p63 and CD31. Journal of Orofacial Sciences, 12(1), 52.
Bazarsad, S., Zhang, X., Kim, K. Y., Illeperuma, R., Jayasinghe, R. D., Tilakaratne, W. M., & Kim, J. (2017). Identification of a combined biomarker for malignant transformation in oral submucous fibrosis. Journal of Oral Pathology & Medicine, 46(6), 431-438.
Chowdhury, P., Nagamalini, B. R., Singh, J., & Ashwini, B. K. (2021). Expression of ?-catenin in oral leukoplakia and oral submucous fibrosis: An immunohistochemical study. Journal of Oral and Maxillofacial Pathology: JOMFP, 25(1), 124.
Divyambika, C. V., Sathasivasubramanian, S., Vidyarani, S., RaviDavid, A., Harinee, S., & Vijayalakshmi, R. (2021). Clinicopathological correlation of cyclooxygenase 2 expression in oral submucous fibrosis: An immunohistochemical study. Journal of International Society of Preventive & Community Dentistry, 11(5), 553.
Ekanayaka, R. P., & Tilakaratne, W. M. (2016). Oral submucous fibrosis: review on mechanisms of malignant transformation. Oral surgery, oral medicine, oral pathology and oral radiology, 122(2), 192-199.
Hosur, M. B., Puranik, R. S., Vanaki, S. S., Puranik, S. R., Sudhakara, M., & Das, S. (2021). Evaluation of immunohistochemical expression of epithelial–mesenchymal transition markers E-cadherin, Twist and Snail in oral submucous fibrosis and their possible association with malignant transformation. Journal of Oral and Maxillofacial Pathology: JOMFP, 25(1), 97.
Joseph, I., Elizabeth, J., Rao, U. K., & Ranganathan, K. (2020). Study of Hypoxia-inducible factor-2? expression in the malignant transformation of Oral submucous fibrosis. Journal of Oral and Maxillofacial Pathology: JOMFP, 24(1), 33.
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg, 8(5), 336-341.
Monteiro, R., Hallikeri, K., & Sudhakaran, A. (2021). PTEN and ?-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis. Journal of oral & maxillofacial research, 12(1).
Nithya, S., Joshua, E., Ranganathan, K., Thavarajah, R., & Rao, U. K. (2019). Loricrin expression and its implication in oral submucous fibrosis, hyperkeratosis and normal mucosa with association to habits–An immunohistochemical study. Journal of Oral Biology and Craniofacial Research, 9(3), 226-231.
Patel, P. N., Thennavan, A., Sen, S., Chandrashekar, C., & Radhakrishnan, R. (2015). Translational approach utilizing COX-2, p53, and MDM2 expressions in malignant transformation of oral submucous fibrosis. Journal of oral science, 57(3), 169-176.
Quan, H., Liu, S., Shan, Z., Liu, Z., Chen, T., Hu, Y., ... & Fang, L. (2020). Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis. Archives of Oral Biology, 119, 104916.
Raju K, L., Haragannavar, V. C., Patil, S., Rao, R. S., Nagaraj, T., Augustine, D., ... & Nambiar, S. (2020). Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma–an Immunohistochemical Analysis. Pathology & Oncology Research, 26(3), 1573-1582.
Sharada, P., Swaminathan, U., Nagamalini, B. R., Kumar, K. V., Ashwini, B. K., & Lavanya, V. L. N. (2018). Coalition of E-cadherin and vascular endothelial growth factor expression in predicting malignant transformation in common oral potentially malignant disorders. Journal of oral and maxillofacial pathology: JOMFP, 22(1), 40.
Sudarshan, R., & Annigeri, R. G. (2012). Pathogenesis of oral submucous fibrosis: The past and current concepts. International Journal of Oral & Maxillofacial Pathology, 3(2), 27-37.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.